Inventor · disambiguated record
Byron H. Arison
Also filed as: ARISON BYRON H
44 granted patents·1 pending application·701 citations·filing 1980–2001
98Inventor score
Files withMERCK & CO INC44
Top patents by PatentIndex Score
45 records- 0194US5952347AQuinoline leukotriene antagonistsMERCK & CO INC·Filed 1998·Granted Sep 14, 1999·80 cites·6 claims
- 0291US4981792AImmunosuppressant compoundMERCK & CO INC·Filed 1988·Granted Jan 1, 1991·34 cites·10 claims
- 0390US5302604ACholesterol lowering compounds produced by directed biosynthesisMERCK & CO INC·Filed 1992·Granted Apr 12, 1994·50 cites·17 claims
- 0488US5192668ASynthesis of protease inhibitorMERCK & CO INC·Filed 1992·Granted Mar 9, 1993·46 cites·1 claims
- 0588US5187074AMethod of hydroxylation with ATCC 55086MERCK & CO INC·Filed 1992·Granted Feb 16, 1993·40 cites·1 claims
- 0686US5049565AMicrobial transformation process for preparing anti-hypertensive productsMERCK & CO INC·Filed 1990·Granted Sep 17, 1991·29 cites·6 claims
- 0784US5053329AProcess for preparation of novel angiotensin II antagonistsMERCK & CO INC·Filed 1991·Granted Oct 1, 1991·26 cites·2 claims
- 0883US6426353B1α v integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Jul 30, 2002·21 cites·15 claims
- 0982US5087702AMicrobial transformation process for producing an antihypertensive productMERCK & CO INC·Filed 1991·Granted Feb 11, 1992·21 cites·6 claims
- 1081US4997849AMicrobial transformation of simvastatinMERCK & CO INC·Filed 1989·Granted Mar 5, 1991·16 cites·3 claims
- 1181US4987139AFK-520 microbial transformation productMERCK & CO INC·Filed 1989·Granted Jan 22, 1991·19 cites·4 claims
- 1279US5149701AC-31 methylated FR-900520 cyclic hemiketal immunosuppressant agentsMERCK & CO INC·Filed 1991·Granted Sep 22, 1992·20 cites·4 claims
- 1378US5225403AC-21 hydroxylated FK-506 antagonistMERCK & CO INC·Filed 1991·Granted Jul 6, 1993·25 cites·6 claims
- 1477US4965200AProcess for the preparation of 3-keto, 5-hydroxy simvastatin analogsMERCK & CO INC·Filed 1989·Granted Oct 23, 1990·16 cites·4 claims
- 1575US5352783AMicrobial transformation product having immunosuppressive activityMERCK & CO INC·Filed 1993·Granted Oct 4, 1994·14 cites·1 claims
- 1675US5210030AProcess for selectively acylating immunomycinMERCK & CO INC·Filed 1990·Granted May 11, 1993·16 cites·3 claims
- 1774US5221625ACyclcic FR-900520 microbial biotransformation agentMERCK & CO INC·Filed 1992·Granted Jun 22, 1993·14 cites·1 claims
- 1874US5068323AThermally re-arranged FK-506 derivatives having immunosuppressant activityMERCK & CO INC·Filed 1990·Granted Nov 26, 1991·14 cites·15 claims
- 1973US5317031ACholesterol lowering compoundsMERCK & CO INC·Filed 1992·Granted May 31, 1994·47 cites·13 claims
- 2073US5215894ABiological process for producing 17β-N-monosubstituted carbamoyl-11-oxo-4-aza-5-α-androst-3-one testosterone-5-α reductase inhibitorsMERCK & CO INC·Filed 1992·Granted Jun 1, 1993·38 cites·7 claims
- 2171US4285963ANovel derivatives of C-076 compoundsMERCK & CO INC·Filed 1980·Granted Aug 25, 1981·30 cites·9 claims
- 2270US4975372AMicrobial transformation product of L-683,590MERCK & CO INC·Filed 1989·Granted Dec 4, 1990·8 cites·7 claims
- 2369US5324644AProcess for producing immunosuppressant agentMERCK & CO INC·Filed 1992·Granted Jun 28, 1994·13 cites·1 claims
- 2461US5273979AC-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agentMERCK & CO INC·Filed 1991·Granted Dec 28, 1993·8 cites·2 claims
- 2555US5290772AImmunosuppressant agentMERCK & CO INC·Filed 1992·Granted Mar 1, 1994·7 cites·2 claims
- 2654US5124258AFermentation process for the preparation of ivermectin aglyconeMERCK & CO INC·Filed 1990·Granted Jun 23, 1992·5 cites·2 claims
- 2753US5138052AL-683,590 microbial transformation productMERCK & CO INC·Filed 1991·Granted Aug 11, 1992·4 cites·1 claims
- 2851US5140042A28-hydroxy ivermectin aglyconeMERCK & CO INC·Filed 1990·Granted Aug 18, 1992·4 cites·4 claims
- 2949US5057608AImmunoregulants, immunosuppressants, process to make ring expanded macrolide related to FK-506/FK-520MERCK & CO INC·Filed 1990·Granted Oct 15, 1991·3 cites·8 claims
- 3045US4738982AHMG-CoA reductase inhibitorsMERCK & CO INC·Filed 1986·Granted Apr 19, 1988·3 cites·3 claims
- 3143US5252612AMicrobial immunosoppressant agentMERCK & CO INC·Filed 1992·Granted Oct 12, 1993·3 cites·3 claims
- 3242US5612217AStreptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of HIV protease inhibitorsMERCK & CO INC·Filed 1994·Granted Mar 18, 1997·4 cites·1 claims
- 3342US5268370AMicrobial transformation product of L-679,934MERCK & CO INC·Filed 1992·Granted Dec 7, 1993·2 cites·4 claims
- 3441US5468771ACholesterol lowering compoundMERCK & CO INC·Filed 1992·Granted Nov 21, 1995·2 cites·5 claims
- 3541US5270187AMicrobial transformation productMERCK & CO INC·Filed 1992·Granted Dec 14, 1993·2 cites·3 claims
- 3641US5250422ABiotransformation process for the production of invermectin derivativesMERCK & CO INC·Filed 1992·Granted Oct 5, 1993·2 cites·15 claims
- 3741US5192671AProcess for the glycosylation of avermectin compoundsMERCK & CO INC·Filed 1991·Granted Mar 9, 1993·8 cites·5 claims
- 3841US2004254211A1Alpha v integrin receptor antagonistsFiled 2001·Application pending·0 cites
- 3938US5272068AProcess for producing immunosuppressant agent L-683942 by fermentationMERCK & CO INC·Filed 1991·Granted Dec 21, 1993·4 cites·1 claims
- 4038US5202258AImmunosuppressant-producing cultureMERCK & CO INC·Filed 1992·Granted Apr 13, 1993·2 cites·1 claims
- 4136US5219985AAntifungal agentMERCK & CO INC·Filed 1990·Granted Jun 15, 1993·1 cites·2 claims
- 4231US5478929ABioconversion products of 27-hydroxy avermectinMERCK & CO INC·Filed 1994·Granted Dec 26, 1995·0 cites·3 claims
- 4330US5362752AChemical compoundsMERCK & CO INC·Filed 1993·Granted Nov 8, 1994·0 cites·8 claims
- 4430US5359096ACholesterol lowering compoundsMERCK & CO INC·Filed 1992·Granted Oct 25, 1994·0 cites·26 claims
- 4526US5169769AMethod of hydroxylating substituted 3-aminopyridinones using mammalian tissueMERCK & CO INC·Filed 1991·Granted Dec 8, 1992·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Byron H. Arison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →